Stocktoria
LIFECORE BIOMEDICAL, INC. \DE\ LFCR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1996-02-15
LIFECORE BIOMEDICAL, INC. \DE\ statistics & valuation
Market cap$193.9M
P / S1.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 31.3% | 32.6% | 27.1% | 35.1% | 38.6% |
| Operating margin | -13.4% | -6.9% | -21.1% | -10.6% | -8.7% |
| Net margin | -30.0% | 9.4% | -96.4% | -104.9% | -32.0% |
| FCF margin | -10.6% | -14.1% | — | -43.9% | -2.8% |
| Return on assets | -16.2% | 4.7% | -39.3% | -42.5% | -6.4% |
| Return on equity | -2898.0% | 106.2% | 2353.7% | -132.9% | -16.0% |
| Debt / equity | 97.63× | 11.02× | -20.06× | 1.12× | 0.82× |
| Current ratio | 2.84 | 2.08 | 2.39 | 0.66 | 1.43 |
| Revenue growth | 0.5% | 24.2% | -7.2% | 10.3% | -37.0% |
Source: SEC EDGAR filings · CIK 0001005286 · as of 2025-05-25. Facts from filings plus Stocktoria's own computed scores — not investment advice.